| Board | Threads | Posts | Last Post | |
|---|---|---|---|---|
 |
Entecavir (Baraclude, Bristol-Myers Squibb, 2005) |
3 | 6 |
8/18/10 Entecavir Reverse Liver Fibrosis,Cirrhosis by 3aplus63gluck Apr 8, 2020 17:54:20 GMT -5 |
|
Peginterferon alfa-2a (Pegasys, Hoffman LaRoche, 2005) |
0 | 0 | No posts have been made on this board. |
|
Tenofovir (Viread, Gilead Sciences, 2008) Viread. Monitoring kidney function is needed with this treatment. |
0 | 0 | No posts have been made on this board. |
|
Interferon alfa-2b (Intron A, Schering, 1991) Interferon. The immune system-boosting medicine interferon alpha is injected for at least 6 months. This drug does not cure the disease, but improves liver inflammation. Long-acting interferon (peginterferon) has also been shown to be useful. Interferon does have some undesirable side effects, including: malaise, depression, and loss of appetite, and it can lower the number of white blood cells. |
0 | 0 | No posts have been made on this board. |
|
Lamivudine (Epivir HBV, Glaxo, 1998) Epivir-HBV is a nucleoside reverse transcriptase inhibitor, used to treat a chronic viral infection of the liver (hepatitis B). It works by slowing the growth of the virus. It is not a cure for hepatitis B and does not prevent the passing of hepatitis B to others. |
0 | 0 | No posts have been made on this board. |
|
Adefovir dipivoxil (Hepsera, Gilead, 2002) Hepsera. This drug works well in people whose disease doesn't respond to Epivir but, in high doses it can cause kidney problems. |
1 | 1 |
8/27/10 Add Adefovir, Lamivudine-Resistant Patient by Chang Sha Sept 1, 2010 8:05:00 GMT -5 |
|
Telbivudine (Tyzeka, Idenix Novartis, 2005) |
0 | 0 | No posts have been made on this board. |
|
News: Other Drug Development |
3 | 3 |
9/1/10 Abbott-FDA Approval for Molecular Test by Chang Sha Sept 1, 2010 9:28:04 GMT -5 |
| Status | Subject | Created By | Replies | Views | Last Post | |
|---|---|---|---|---|---|---|
| No threads were found. | ||||||